Evidence map›Paper›PMID 35970686›Full record

ArticleNutrition, metabolism, and cardiovascular diseases : NMCD2022

Association of nut consumption with CVD risk factors in young to middle-aged adults: The Coronary Artery Risk Development in Young Adults (CARDIA) study.

So-Yun Yi, Lyn M Steffen, Xia Zhou, James M Shikany, David R Jacobs

Abstract read
In one paragraph

Article in Nutrition, metabolism, and cardiovascular diseases : NMCD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Effects of Walnut (Juglans regia L.) on Blood Pressure and Endothelial Function in Adults: A Systematic Review and Dose-Response Meta-Analysis.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2026
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

So-Yun YiUniversity of Minnesota School of Public Health, Division of Epidemiology and Community Health; Minneapolis, MN, USA.
Lyn M SteffenUniversity of Minnesota School of Public Health, Division of Epidemiology and Community Health; Minneapolis, MN, USA. Electronic address: steffen@umn.edu.
Xia ZhouUniversity of Minnesota School of Public Health, Division of Epidemiology and Community Health; Minneapolis, MN, USA.
James M ShikanyDivision of Preventive Medicine, School of Medicine, University of Alabama at Birmingham; Birmingham, AL, USA.
David R JacobsUniversity of Minnesota School of Public Health, Division of Epidemiology and Community Health; Minneapolis, MN, USA.

Funding

Genes of the CYP450-Derived Eicosanoids Pathway in Subclinical AtherosclerosisR01HL084099 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FORNAGE, MYRIAM · 2007 to 2010
$2.8M
NHLBI NIH HHS HHSN268201800003INHLBI NIH HHS HHSN268201800004INHLBI NIH HHS HHSN268201800005INHLBI NIH HHS HHSN268201800006INHLBI NIH HHS HHSN268201800007INHLBI NIH HHS R01 HL084099
6 · The paper itself

Abstract

BACKGROUND AND

aimsFew studies have examined long-term associations of walnut, other nut, and no nut consumption with cardiovascular disease (CVD) risk factors. Results from prospective studies with long-term follow-up can provide further evidence for dietary guideline messaging to consume nuts. Therefore, we examined the associations of walnut, other nut, and no nut consumption with diet quality and CVD risk factors over 30 years of follow-up. METHODS AND

resultsData were analyzed from 3092 young adults enrolled in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Dietary intake, including walnuts and other nuts, was assessed 3 times over 20 years. CVD risk factors were measured at multiple exams. General linear regression evaluated the associations of walnut, other nut, and no nut consumption with CVD risk factors over 30 years (Y30) of follow-up. The 20-year cumulative mean intake of walnuts (0.74 oz/d), other nuts (1.6 oz/d), or no nut consumption was differentially associated with HEI-2015 and CVD risk factors by Y30. Generally, walnut consumers had significantly higher HEI-2015, lower body mass index, waist circumference, blood pressure, and triglyceride concentration, and gained less weight since baseline than other nut consumers (p ≤ 0.05 for all). Further, walnut consumers had lower fasting blood glucose than no nut consumers (p ≤ 0.05).

conclusionStudy findings that walnut and other nut consumption was associated with better CVD risk factors and diet quality aligns with the 2020-2025 US. Dietary Guidelines for Americans recommendation to consume nuts, such as walnuts, within the context of a healthy diet.

Indexed as

Cardiovascular DiseasesJuglansBlood GlucoseCoronary VesselsDietHumansMiddle AgedNutsProspective StudiesRisk FactorsTriglyceridesYoung AdultBlood GlucoseTriglyceridesCVD risk FactorsHealthy dietNutsObesityObservational studyWalnuts

Identifiers

PMID35970686
PMCPMC9529993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.